The Bacillus Calmette-Guérin (BCG) vaccine is primarily used to prevent tuberculosis (TB), particularly in children, and is also being investigated for its potential non-specific immune-boosting effects against other infections and certain cancers. Despite its widespread use, the efficacy of the BCG vaccine varies geographically, and it is not commonly used in countries with a low incidence of TB, like the United States.